the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

* View All Categories
View Conferences

Market Research Report

Abbott Laboratories Medical Device Company Intelligence Report

Published by Espicom Business Intelligence Contact us : +1-860-674-8796
Published 2009/10 Content info 50 PAGES
Product code ES17862
Price From  US $ 560 Order/Price list
US $ 560 Hard Copy
US $ 560 PDF by E-mail (Single User License)
US $ 560 Web Access (Single User License)
Delivery Time
PDF by E-Mail
Approx. 1-2 business days
Hard Copy/CD-ROM
Approx. 3-4 business days
If you need expedited delivery, please call us.
Description TOC

Abstract

Abbott' s medical devices include cardiovascular, spinal orthopaedic, blood glucose monitoring and point-of-care diagnostic products. This report provides a full review of the company' s activities.

Abbott Laboratories, headquartered in Illinois, USA, is a diversified healthcare company engaged in the development, manufacture and marketing of pharmaceutical, nutritional, diagnostic and medical device products. Abbott markets its products in over 130 countries, employs nearly 67,000 people and generated revenue of US$22.5 billion in fiscal 2006.

This profile focuses on Abbott' s medical devices which include a range of vascular, spinal, blood glucose monitoring and point-of-care diagnostic products, all of which it has acquired in recent years. The company also offered a broad range of medication delivery systems such as electronic drug-delivery systems, infusion therapy and critical care products, but spun-off these operations into a publicly-traded company, Hospira, in April 2004.

Currently, Abbott' s medical device businesses are as follows:

Abbott Vascular - Formed by Abbott acquiring several product lines from bankrupt Jomed, as well as Biocompatibles' coronary and peripheral interventional business, Integrated Vascular Systems and Perclose. Significantly expanded in April 2006 through the acquisition of Guidant' s vascular intervention and endovascular solutions businesses, including the Xience V drug-eluting stent (DES). Abbott Vascular now offers interventional cardiology products, devices for biliary and peripheral intervention, carotid stent and embolic protection systems, and vascular closure products.

Abbott Spine - Formed after the acquisition of Spinal Concepts and expanded in October 2004 by the acquisition of Spine Next. Based in Austin, Texas, USA, and Bordeaux, France. Offers the Wallis dynamic stabilisation device outside the US, as well as products for thoracolumbar fixation, cervical plates and other traditional products for spinal fusion surgeries.

Abbott Diabetes Care - Includes the acquired companies, TheraSense and MediSense. Based in Alameda, California, USA, it offers glucose monitoring systems and test strips for use in home and hospital settings. Its brands include Precision and FreeStyle.

Abbott Point-of-Care - Formed through the acquisition of i-STAT in January 2004. It offers a hand-held analyser and single-use cartridges that include tests for electrolytes, metabolytes, blood gases, coagulation and cardiac markers that deliver results at the patient' s bedside. Based in East Windsor, New Jersey, USA.

Related Report
Back to Top
Please inform me when related publications are released
InfoWatch

US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.